<i>Brevibacterium casei</i>isolated as a cause of relapsing peritonitis

Althaf, Mohammed Mahdi; Abdelsalam, Mohamed Said; Al-Sunaid, Mohammed; Hussein, Maged H.

doi:10.1136/bcr-2014-203611

Cited by 12 publications

(11 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Higher risk of all-cause cardiovascular events in hemodialysis group aligns with contemporary literature that it is accounted for by thrombotic events, vein injury, fibrosis and stenosis associated with central vein access devices such as dialysis catheters [40][41][42]. The statistically insignificant differences in risk of all-cause infections between the 2 groups could be accounted for by the fact that both modalities are associated with dialysis devices induced infections [43][44][45][46][47]; peritoneal dialysis with peritonitis [48,49] and hemodialysis with central vein access-devices infections [41,42]. Statistical insignificant difference between the risk of lupus flares in the 2 comparison groups could be explained by the fact that SLE activity undergoes quiescence, "burn out", when a lupus nephritis patient progresses to ESRD [15,18] and during RRT as shown by Gonzalez-Pulido et al (2014) [50], ideally due to immunosuppressants administration as illustrated by Maroz et al (2013) [51].…”

Section: Discussionsupporting

confidence: 77%

Systematic review and meta-analysis of clinical outcomes comparison between different initial dialysis modalities in end-stage renal disease patients due to lupus nephritis prior to renal transplantation

et al. 2020

View full text Add to dashboard Cite

Background: Regarding lupus disease activity, morbidity and survival, limited literature concluded conflicting results when comparing hemodialysis versus peritoneal dialysis as initial renal replacement therapies (RRT) prior to transplantation, in lupus nephritis end-stage renal disease (LN-ESRD) patients. This study was aimed to compare the risks of lupus flares, all-cause infections, all-cause cardiovascular events, and mortality, between hemodialysis versus peritoneal dialysis as initial RRT-modality before renal-transplant in LN-ESRD patients, by systematic review and meta-analysis. Methods: PubMed, EMBASE, and SCOPUS were searched for observational-studies comparing LN-ESRD-patients undergoing hemodialysis (Group1) versus peritoneal-dialysis (Group 2) prior to renal-transplantation, by their risks of lupus flare, all-cause infections, all-cause cardiovascular events, and mortality as outcome measures. Relative-Risks of outcomes between the groups measured overall effects at a 95% significance level. RevMan 5.3 computer software was used for analysis. Results: From search, 16 eligible studies reported 15,636 LN-ESRD-patients prior to renal transplantation with 4616 patients on hemodialysis, 2089 on peritoneal dialysis, 280 directly underwent kidney transplantation, 8319 were eliminated with reasons and 332 participants' details were not reported. Hemodialysis group had higher risk of allcause cardiovascular events, Relative-Risk = 1.44 (Confidence Interval:1.02, 2.04), p-Value< 0.05. With regards to risks for mortality, flare and all-cause infections, there were trends that were not statistically significant (p-Value> 0.05). Conclusion: Except for all-cause cardiovascular events in which peritoneal dialysis is superior to hemodialysis offering better outcomes, both treatment modalities offer more or less similar clinical outcomes as effective initial choices of RRT in LN-ESRD patients prior to renal transplant.

show abstract

Section: Discussionsupporting

confidence: 77%

Systematic review and meta-analysis of clinical outcomes comparison between different initial dialysis modalities in end-stage renal disease patients due to lupus nephritis prior to renal transplantation

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Brevibacterium sp. have been implicated in several infections such as peritonitis [1], bacteremia [4], bone infection [7], [8], pericardial infection [2], endocarditis [3], brain abscess [5]. These organisms have emerged as opportunistic pathogens in most reported cases; patients had underlying malignancy or immunodeficiency disease [10].…”

Section: Case Presentationmentioning

confidence: 99%

Brevibacterium massiliense bacteremia

Vecten

Gouriet

Cano

et al. 2017

IDCases

View full text Add to dashboard Cite

show abstract

“… 10 Brevibacterium was first described in 1953 by Dr. Robert Breed, 11 and the first reported isolation of B. casei from clinical cases was documented by Gruner E et al, in 1993 from Switzerland. 12 Thereafter, Brevibaterium species have now been identified as a cause of peritonitis in dialysis patients, 13 – 17 catheter- related bloodstream infection, 18 brain abscess, 19 and endocarditis, pericarditis, osteomyelitis, endophthalmitis, discitis. Cases of peritonitis have been reported due to Brevibacterium otidis 14 and Brevibacterium iodinum 13 and two relapsing peritonitis cases with B. casei .…”

Section: Discussionmentioning

confidence: 99%

Brevibacterium casei induced peritonitis in a patient undergoing continuous cycler peritoneal dialysis: Case report and Literature review

Roy¹,

Garcha²,

Patel³

et al. 2022

Journal of Community Hospital Internal Medicine Perspectives

View full text Add to dashboard Cite

Brevibacterium casei is an extremely rare organism that can lead to peritonitis in End-stage renal disease patients of peritoneal dialysis. Out of only five overall Brevibacterium species peritonitis reported worldwide, only two of them had B. casei subspecies peritonitis detected, with both needing peritoneal dialysis catheter removal and change in dialysis modality to hemodialysis. Our patient, an elderly 63-year-old Hispanic male, was on peritoneal dialysis at home and presented with features suggestive of peritonitis. He was diagnosed subsequently with B. casei and started on broad spectrum intraperitoneal antibiotics. However, he did not need dialysis modality change and recovered fully after 3 weeks of appropriate intraperitoneal antibiotics therapy. Longer antibiotics therapy and frequent clinical follow-up plus better clinician awareness are needed to prevent this rare infection.

show abstract

Brevibacterium caseiisolated as a cause of relapsing peritonitis

Cited by 12 publications

References 6 publications

Systematic review and meta-analysis of clinical outcomes comparison between different initial dialysis modalities in end-stage renal disease patients due to lupus nephritis prior to renal transplantation

Systematic review and meta-analysis of clinical outcomes comparison between different initial dialysis modalities in end-stage renal disease patients due to lupus nephritis prior to renal transplantation

Brevibacterium massiliense bacteremia

Brevibacterium casei induced peritonitis in a patient undergoing continuous cycler peritoneal dialysis: Case report and Literature review

Contact Info

Product

Resources

About